Jazz Pharmaceuticals
JAZZ
JAZZ
360 hedge funds and large institutions have $7.5B invested in Jazz Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 137 increasing their positions, 129 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
46% less funds holding in top 10
Funds holding in top 10: 13 → 7 (-6)
47% less call options, than puts
Call options by funds: $51.8M | Put options by funds: $98.7M
Holders
360
Holding in Top 10
7
Calls
$51.8M
Puts
$98.7M
Top Buyers
| 1 | +$221M | |
| 2 | +$128M | |
| 3 | +$37.9M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.1M |
| 5 |
CCM
Cadian Capital Management
New York
|
+$20.4M |
Top Sellers
| 1 | -$75.9M | |
| 2 | -$74.4M | |
| 3 | -$38.5M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$38.2M |
| 5 |
CM
Churchill Management
Los Angeles,
California
|
-$30.2M |